The Future of Cellular Immunotherapy

Highly Automated Precision Medicine

[wpbb post:title]
Matthew Hewitt, PhD, Head of R&D (a.i.) and Clinical Development, Personalized Medicine and Stacey Willard, PhD, Director of Product Management, IsoPlexis
  • Learn how our unique technology is playing a critical part in advancing cellular immunotherapy

  • Discover how IsoPlexis is changing the way cell therapies are developed & manufactured

  • Review several publications & case studies

2020-09-21T04:55:05-04:00